Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1996-2-23
pubmed:abstractText
Deglycosylation of viral glycoproteins has been suggested to influence the number of available T cell determinants and to increase T cell recognition of antigens. In this study, we have investigated whether T cell responses to the HIV-1 envelope glycoprotein gp160 were influenced by deletion of three N-glycans of the protein. Wild type (wt) and a mutated form of gp160 (gp160A123) lacking the three N-glycans in the C-terminal CD4-binding region efficiently induced antigen-specific T cell responses in mice of the H-2b, H-2d, and H-2k haplotypes. Further, T cells primed by either wt gp160 or gp160A123 were stimulated in vitro to a similar extent by the homologous and heterologous protein, indicating that deletion of the glycans did not affect the overall immunogenicity and antigenicity of gp160A123. Wild-type gp160 and gp160A123 induced comparable T cell responses to those of epitopes which with respect to the secondary structure of gp160 were distant from the deleted glycans. However, in mice of the H-2b haplotype, wt gp160 primed T cells which responded in vitro to a peptide containing one of the deleted N-glycosylation sites (Asn448), whereas T cells induced by gp160A123 were unable to recognize this peptide. Thus, deletion of the glycans abrogated the in vivo priming of T cells recognizing an epitope in close proximity to the deletion sites. Furthermore, enzymatically deglycosylated gp160 failed to induce a T cell response to this epitope. These results indicate that the in vivo generation of certain T cell determinants from glycoproteins is dependent on the glycosylation of the protein.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0042-6822
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
215
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
124-33
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:8560759-Amino Acid Sequence, pubmed-meshheading:8560759-Animals, pubmed-meshheading:8560759-Antigens, CD4, pubmed-meshheading:8560759-Asparagine, pubmed-meshheading:8560759-CD4-Positive T-Lymphocytes, pubmed-meshheading:8560759-Epitopes, pubmed-meshheading:8560759-Female, pubmed-meshheading:8560759-Gene Products, env, pubmed-meshheading:8560759-Glycosylation, pubmed-meshheading:8560759-HIV Envelope Protein gp160, pubmed-meshheading:8560759-HIV-1, pubmed-meshheading:8560759-Humans, pubmed-meshheading:8560759-Mice, pubmed-meshheading:8560759-Mice, Inbred BALB C, pubmed-meshheading:8560759-Mice, Inbred C57BL, pubmed-meshheading:8560759-Mice, Inbred CBA, pubmed-meshheading:8560759-Molecular Sequence Data, pubmed-meshheading:8560759-Polysaccharides, pubmed-meshheading:8560759-Protein Precursors, pubmed-meshheading:8560759-Species Specificity, pubmed-meshheading:8560759-Structure-Activity Relationship
pubmed:year
1996
pubmed:articleTitle
N-linked glycans in the CD4-binding domain of human immunodeficiency virus type 1 envelope glycoprotein gp160 are essential for the in vivo priming of T cells recognizing an epitope located in their vicinity.
pubmed:affiliation
Department of Veterinary Microbiology, College of Veterinary Medicine, Swedish University of Agricultural Sciences, Uppsala, Sweden.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't